SIGA Technologies (NASDAQ:SIGA) Stock Price Down 2.4%

SIGA Technologies, Inc. (NASDAQ:SIGA) traded down 2.4% during trading on Tuesday . The stock traded as low as $8.23 and last traded at $8.23. 11,983 shares were traded during mid-day trading, a decline of 99% from the average session volume of 960,012 shares. The stock had previously closed at $8.43.

SIGA Technologies Stock Performance

The firm has a market cap of $574.67 million, a P/E ratio of 7.40 and a beta of 0.91. The business’s 50-day simple moving average is $9.01 and its 200 day simple moving average is $8.36.

SIGA Technologies (NASDAQ:SIGA) last released its earnings results on Thursday, August 1st. The company reported $0.03 earnings per share (EPS) for the quarter. The company had revenue of $21.81 million during the quarter. SIGA Technologies had a net margin of 48.55% and a return on equity of 51.40%. During the same period in the prior year, the company posted ($0.04) earnings per share. As a group, equities research analysts expect that SIGA Technologies, Inc. will post 1.01 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of SIGA Technologies by 1.9% during the 1st quarter. Vanguard Group Inc. now owns 2,283,612 shares of the company’s stock worth $19,548,000 after acquiring an additional 41,515 shares in the last quarter. AltraVue Capital LLC raised its stake in SIGA Technologies by 6.6% in the second quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock valued at $16,528,000 after buying an additional 134,450 shares during the last quarter. Tidal Investments LLC purchased a new stake in shares of SIGA Technologies during the first quarter worth about $157,000. Hillsdale Investment Management Inc. purchased a new position in shares of SIGA Technologies in the 1st quarter valued at approximately $1,367,000. Finally, LSV Asset Management acquired a new stake in SIGA Technologies in the 2nd quarter worth approximately $807,000. Hedge funds and other institutional investors own 55.40% of the company’s stock.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.